Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-03-11 | Ian C. Read Chairman of the Board and CEO, Pfizer, Inc. AC (Chair) EC ü |
| 2017-02-27 | Ian C. Read Chairman of the Board and CEO Pfizer, Inc. AC (Chair) EC ✓ Audit Committee Financial Expert Leadership experience as a CEO International experience Provides diversity of background/viewpoint Marketing, compensation, governance and public company board experience 2016 Outside Director Compensation: Fees Earned or Paid in Cash($) 100,000 Stock Awards($) 185,000 All Other Compensation($) 7,440 Total($) 292,440 |
| 2018-03-16 | Mr. Read was elected Chairman of the Board and Chief Executive Officer of Pfizer, Inc. The Board has determined that all directors and nominees, except for Thomas J. Falk and Michael D. Hsu, are Independent Directors. Mr. Read satisfies the financial literacy requirements of the NYSE. Mr. Read's total compensation in 2017 was $319,280. |
| 2019-03-08 | Mr. Read was elected Executive Chairman in January 2019 of Pfizer, Inc., a drug manufacturer. Prior to that, he served as Chairman of the Board and Chief Executive Officer since December 2011 and President and Chief Executive Officer since December 2010. Mr. Read joined Pfizer in 1978 in its financial organization. |
| 2020-03-06 | Mr. Read is former Chairman and CEO of Pfizer, Inc. Chair of Management Development and Compensation Committee and Executive Committee. 2019 total compensation: $320,000. |
| 2021-03-08 | Ian C. Read Former Chairman of the Board and Chief Executive Officer, Pfizer, Inc. Other public company boards served on since 2015: DXC Technology Company (since March 2020), Pfizer, Inc. (through December 2019), Population Health Investment Co., Inc. (since November 2020) and Viatris Inc. (since November 2020). Management Development and Compensation Committee Nominating and Corporate Governance Committee 2020 Outside Director Compensation Ian C. Read 100,000 210,000 — 310,000 |
Data sourced from SEC filings. Last updated: 2025-07-01